Prognostic significance and therapeutic potential of the immune checkpoint VISTA in pancreatic cancer
Authors (first, second and last of 11)
The "Journal of Cancer Research and Clinical Oncology" publishes significant and up-to-date articles within the fields of experimental and clinical oncology. The journal, which is chiefly devoted to Original papers, also includes Reviews as well as Editorials and Guest editorials on current, controversial topics. The section Letters to the editors provides a forum for a rapid exchange of comments and information concerning previously published papers and topics of current interest. Meeting reports provide current information on the latest results presented at important congresses.
The following fields are covered: carcinogenesis - etiology, mechanisms; molecular biology; recent developments in tumor therapy; general diagnosis; laboratory diagnosis; diagnostic and experimental pathology; oncologic surgery; and epidemiology.
- Official Journal of the German Cancer Society (Deutsche Krebsgesellschaft)
- Publishes significant and up-to-date articles within the fields of experimental and clinical oncology
- Presents original papers, reviews, rapid communications, letters and editorials
- 100% of authors who answered a survey reported that they would definitely publish or probably publish in the journal again
Journal information
- Editor-in-Chief
-
- Klaus Höffken
- Publishing model
- Hybrid. Learn about publishing OA with us
Journal metrics
- 3.656 (2019)
- Impact factor
- 3.295 (2019)
- Five year impact factor
- 13 days
- Submission to first decision
- 85 days
- Submission to acceptance
- 337,049 (2019)
- Downloads
Latest issue
Latest articles
-
-
Mitochondrial DNA analysis efficiently contributes to the identification of metastatic contralateral breast cancers
Authors (first, second and last of 10)
-
-
Rapamycin inhibits lung squamous cell carcinoma growth by downregulating glypican-3/Wnt/β-catenin signaling and autophagy
Authors (first, second and last of 5)
-
Journal updates
-
COVID-19 and impact on peer review
As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times. Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.
About this journal
- Electronic ISSN
- 1432-1335
- Print ISSN
- 0171-5216
- Abstracted and indexed in
-
- AGRICOLA
- BIOSIS
- Biological Abstracts
- CAB Abstracts
- CNKI
- Chemical Abstracts Service (CAS)
- Current Contents/ Life Sciences
- Dimensions
- EBSCO Academic Search
- EBSCO Biomedical Reference Collection
- EBSCO Discovery Service
- EBSCO STM Source
- EMBASE
- Elsevier Biobase
- Google Scholar
- INIS Atomindex
- Institute of Scientific and Technical Information of China
- Japanese Science and Technology Agency (JST)
- Journal Citation Reports/Science Edition
- Medline
- Naver
- OCLC WorldCat Discovery Service
- Pathway Studio
- ProQuest Biological Science Database
- ProQuest Central
- ProQuest Health & Medical Collection
- ProQuest Health Research Premium Collection
- ProQuest Medical Database
- ProQuest Natural Science Collection
- ProQuest Oncogenes and Growth Factors Abstracts
- ProQuest Pharma Collection
- ProQuest Public Health Database
- ProQuest Research Library
- ProQuest SciTech Premium Collection
- ProQuest-ExLibris Primo
- ProQuest-ExLibris Summon
- Qinsight
- Reaxys
- SCImago
- SCOPUS
- Science Citation Index
- Science Citation Index Expanded (SciSearch)
- Semantic Scholar
- TD Net Discovery Service
- UGC-CARE List (India)
- Copyright information
